Related Experiment Video
Updated: Aug 19, 2025
An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
Published on: November 28, 2010
Integration of local and systemic immunity in ovarian cancer: Implications for immunotherapy
Alicja Rajtak1, Marta Ostrowska-Leśko1,2, Klaudia Żak3
11st Chair and Department of Oncological Gynecology and Gynecology, Medical University of Lublin, Lublin, Poland.
Abstract:
Cancer is a disease that induces many local and systemic changes in immunity. The difficult nature of ovarian cancer stems from the lack of characteristic symptoms that contributes to a delayed diagnosis and treatment. Despite the enormous progress in immunotherapy, its efficacy remains limited. The heterogeneity of tumors, lack of diagnostic biomarkers, and complex immune landscape are the main challenges in the treatment of ovarian cancer. Integrative approaches that combine the tumor microenvironment - local immunity - together with periphery - systemic immunity - are urgently needed to improve the understanding of the disease and the efficacy of treatment. In fact, multiparametric analyses are poised to improve our understanding of ovarian tumor immunology. We outline an integrative approach including local and systemic immunity in ovarian cancer. Understanding the nature of both localized and systemic immune responses will be crucial to boosting the efficacy of immunotherapies in ovarian cancer patients.
Insights
Understanding local and systemic immunity in ovarian cancer is key to improving immunotherapy. Integrative analysis of the tumor microenvironment and systemic immunity is crucial for effective treatment strategies.
Area of Science:
- Immunology
- Oncology
Background:
- Ovarian cancer presents diagnostic challenges due to vague symptoms, leading to delayed treatment.
- Despite advances in immunotherapy, its effectiveness in ovarian cancer is limited by tumor heterogeneity, lack of biomarkers, and a complex immune landscape.
Purpose of the Study:
- To highlight the need for integrative approaches combining local and systemic immunity in ovarian cancer research.
- To emphasize the importance of multiparametric analyses for a comprehensive understanding of ovarian tumor immunology.
Main Methods:
- Outlining an integrative research approach for ovarian cancer.
- Focusing on the analysis of both local (tumor microenvironment) and systemic immunity.
Main Results:
- Integrative analysis of local and systemic immunity provides a more complete picture of ovarian cancer.
- Multiparametric analyses enhance the understanding of the immune landscape in ovarian tumors.
Conclusions:
- Understanding the interplay between local and systemic immune responses is critical for advancing ovarian cancer treatment.
- Integrating insights from the tumor microenvironment and systemic immunity is essential to boost immunotherapy efficacy in ovarian cancer patients.
More Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
01:27Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
01:19Psychoneuroimmunology: Diabetes and Cancer
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...